HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The course of response to focal/grid photocoagulation for diabetic macular edema.

AbstractPURPOSE:
The purpose of this study was to determine whether eyes with center-involved diabetic macular edema, treated with focal/grid photocoagulation, in which there is a reduction in central subfield thickness (CST) measured with optical coherence tomography after 16 weeks, will continue to improve if retreatment is deferred.
METHODS:
This is a prospective, multicenter, observational, single-group focal/grid photocoagulation study of 122 eyes with center-involved diabetic macular edema (optical coherence tomography CST > or =250 microm). At the 16-week visit and continuing every 8 weeks, eyes were assessed for retreatment and additional laser treatment was deferred if the visual acuity letter score improved > or =5 letters or optical coherence tomography CST decreased > or =10% compared with the visit 16 weeks prior.
RESULTS:
Of the 115 eyes that completed the 16-week visit, 54 (47%) had a decrease in CST by > or =10% compared with baseline. Of these, 26 (48%) had a CST > or =250 microm at 16 weeks and were evaluable at 32 weeks. Eleven (42%; 95% confidence interval, 23-63%) of the 26 eyes had a further decrease in CST > or =10% from 16 weeks to 32 weeks without further treatment.
CONCLUSION:
Sixteen weeks after focal/grid laser for diabetic macular edema in eyes with a definite reduction, but not resolution, of central edema, 23% to 63% likely will continue to improve without additional treatment.
AuthorsDiabetic Retinopathy Clinical Research Network
JournalRetina (Philadelphia, Pa.) (Retina) 2009 Nov-Dec Vol. 29 Issue 10 Pg. 1436-43 ISSN: 1539-2864 [Electronic] United States
PMID19898182 (Publication Type: Clinical Trial, Journal Article, Multicenter Study, Research Support, N.I.H., Extramural)
Topics
  • Aged
  • Diabetes Mellitus, Type 1 (complications)
  • Diabetes Mellitus, Type 2 (complications)
  • Diabetic Retinopathy (physiopathology, surgery)
  • Female
  • Fluorescein Angiography
  • Humans
  • Laser Coagulation (methods)
  • Macular Edema (physiopathology, surgery)
  • Male
  • Middle Aged
  • Prospective Studies
  • Retreatment
  • Tomography, Optical Coherence
  • Treatment Outcome
  • Visual Acuity (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: